Výsledky vyhledávání - "Zbigniew, Peruga"

Rivaroxaban in patients with a recent acute coronary syndrome

Autor: Keith Fox, Konstantin Ramshev, Jacek Kubica, Miguel Urina, Kamal Sharma, Frans Van de Werf, Jonathan Townend, Stella Macin, Aleksandar Neskovic, Olga Mirolyubova, Marcelo Sanmartin-Fernandez, Fabio Ghezzi, Roman Libis, Fernando Lanas, Joaquin J Alonso, Meyer ELBAZ, Piotr Ponikowski, Robert Welsh, Jan Zbigniew Peruga

Publikováno v: The New England Journal of Medicine, 366, 1, pp. 9-19
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
The New England Journal of Medicine, 366, 9-19
Mega, J L, Braunwald, E, Wiviott, S D, Bassand, J-P, Bhatt, D L, Bode, C, Burton, P, Cohen, M, Cook-Bruns, N, Fox, K A A, Goto, S, Murphy, S A, Plotnikov, A N, Schneider, D, Sun, X, Verheugt, F W A, Gibson, C M, ATLAS ACS 2–TIMI 51 Investigators & Jensen, S E 2012, ' Rivaroxaban in patients with a recent acute coronary syndrome ', The New England Journal of Medicine, vol. 366, no. 1, pp. 9-19 . https://doi.org/10.1056/NEJMoa1112277

Item does not contain fulltext BACKGROUND: Acute coronary syndromes arise from coronary atherosclerosis with superimposed thrombosis. Since factor Xa plays a central role in thrombosis, the inhibition of factor Xa with low-dose rivaroxaban might impr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2d3bc0b6b1b9cb177f7cc534398b08c
https://hdl.handle.net/2066/109424

Zobrazit plný text záznamu

[Left atrial appendage elimination using Amplatzer Cardiac Plug in patients with atrial fibrillation - report of two cases]

Autor: Michał, Plewka, Jarosław D, Kasprzak, Jan Zbigniew, Peruga, Jai-Wun, Park, Piotr, Lipiec

Publikováno v: Kardiologia polska. 69(1)

Percutaneous left atrial appendage device closure is currently under evaluation as a method for reducing stroke risk in patients with atrial fibrillation and contraindications for long-term oral anticoagulation therapy. We present two cases of succes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b157e907932208050230a45bb0af3668
https://pubmed.ncbi.nlm.nih.gov/21267978

Zobrazit plný text záznamu

Influence of treatment strategy on serum adiponectin, resistin and angiogenin concentrations in patients with stable multivessel coronary artery disease after one-year follow-up

Autor: Radosław, Kręcki, Maria, Krzemińska-Pakuła, Jan Zbigniew, Peruga, Piotr, Szcześniak, Piotr, Lipiec, Daria, Orszulak-Michalak, Jarosław Damian, Kasprzak

Publikováno v: Kardiologia polska. 68(12)

Adiponectin and resistin, as well as the novel angiogenetic factor angiogenin, may be associated with inflammation and atherosclerosis. However, the available data are limited regarding adipocytokines and angiogenesis factors long-term serum concentr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0b22463e5d1b9ba68d3eb6bbd6d63ae1
https://pubmed.ncbi.nlm.nih.gov/21174282

Zobrazit plný text záznamu

Relationship of serum angiogenin, adiponectin and resistin levels with biochemical risk factors and the angiographic severity of three-vessel coronary disease

Autor: Radosław, Kręcki, Maria, Krzemińska-Pakuła, Jarosław, Drożdż, Piotr, Szcześniak, Jan Zbigniew, Peruga, Piotr, Lipiec, Daria, Orszulak-Michalak, Jarosław D, Kasprzak

Publikováno v: Cardiology journal. 17(6)

Patients with advanced coronary artery disease (CAD) have an unfavorable prognosis. Therefore, early identification of this high-risk group is important. The aim of this study was to assess the usefulness of clinical, electrocardiographic and echocar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2cc18e356cd1b72b2c2c65091504f979
https://pubmed.ncbi.nlm.nih.gov/21154263

Zobrazit plný text záznamu

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Publikováno v: Swedberg, K, Komajda, M, Böhm, M, Borer, J S, Ford, I, Dubost-Brama, A, Lerebours, G, Tavazzi, L, SHIFT Investigators & Gøtzsche, O 2010, ' Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study ', Lancet, vol. 376, no. 9744, pp. 875-85 . https://doi.org/10.1016/S0140-6736(10)61198-1

Udgivelsesdato: 2010-Sep-11 BACKGROUND: Chronic heart failure is associated with high mortality and morbidity. Raised resting heart rate is a risk factor for adverse outcomes. We aimed to assess the effect of heart-rate reduction by the selective sin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea2074c9e4b1a804f7c371a9dc2aeb4a

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání